Tokyo court rejects Shire claim against Roche haemophilia drug

Chugai, which is 60 percent Roche-owned and which developed Hemlibra, said it expected no change to its financial prospects due to the ruling. “Tokyo District Court rendered a decision in favour of Chugai’s claim,” Chugai said on its website. “(Shire’s …
( read original story …)


Related Post

Tokyo 2020 unveils budget cuts
views 173
Tokyo 2020 organisers Friday unveiled a "significa...
Western banks make push into Japanese dealmaking a...
views 163
HONG KONG/SINGAPORE/TOKYO (Reuters) - Western bank...
New deals as Saudi King courts Japan
views 258
Saudi Arabia and Japan have signed agreements to c...
Nikkei slips from 2-year peak after North Korea br...
views 205
TOKYO, Sept 22 (Reuters) - Japan’s Nikkei share av...
Japan looks to deepen business relationship with O...
views 62
The state of Ohio and Japan have been doing busine...
Citi to Move 1,200 Workers in Tokyo Office Shift
views 264
Sign up here to receive our newsletter. Citigroup ...
Japan life insurers look to diversify foreign bond...
views 272
Japan's life insurers have traditionally stuck to ...
5.6-magnitude earthquake injures five on JapanR...
views 113
Tokyo: A 5.6-magnitude quake hit western Japan ear...
Japan’s Shinzo Abe agrees to keep close contact wi...
views 308
Japanese Prime Minister Shinzo Abe said on Monday ...
Japan’s massive savings pool draws Aussie fu...
views 282
Finance Minister Senator Mathias Cormann spent the...